Syndecans and diabetic complications: a narrative review

Am J Med Sci. 2024 Apr 30:S0002-9629(24)01210-2. doi: 10.1016/j.amjms.2024.04.017. Online ahead of print.ABSTRACTSyndecan (SDC) is a member of the heparan sulfate proteoglycan (HSPG) family. It appears to play a role in the aetiology of diabetic complications, with decreased levels of SDCs being reported in the kidney, retina, and cardiac muscle in models of diabetes mellitus (DM). The reduced levels of SDCs may play an important role in the development of albuminuria in DM. Some studies have provided the evidence supporting the mechanisms underlying the role of SDCs in DM. However, SDCs and the molecular mechanisms involved are complex and need to be further elucidated. This review focuses on the underlying molecular mechanisms of SDCs that are involved in the development and progression of the complications of DM, which may help in developing new strategies to prevent and treat these complications.PMID:38697476 | DOI:10.1016/j.amjms.2024.04.017
Source: The American Journal of the Medical Sciences - Category: General Medicine Authors: Source Type: research